Hadas Cohen-Dvashi, Ph.D.
Affiliations: | 2011 | Weizmann Institute of Science, Rehovot, Israel |
Area:
Cell Biology, Oncology, Neuroscience BiologyGoogle:
"Hadas Cohen-Dvashi"Parents
Sign in to add mentorYosef Yarden | grad student | 2011 | Weizmann Institute | |
(The involvement of Neuron Navigator 3 (NAV3) in EGF-induced cell migration and in cancer.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Kreer C, Zehner M, Weber T, et al. (2020) Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients. Cell |
Cohen-Dvashi H, Amon R, Agans KN, et al. (2020) Rational design of universal immunotherapy for TfR1-tropic arenaviruses. Nature Communications. 11: 67 |
Ehrhardt SA, Zehner M, Krähling V, et al. (2019) Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV. Nature Medicine |
Cohen-Dvashi H, Kilimnik I, Diskin R. (2018) Structural basis for receptor recognition by Lujo virus. Nature Microbiology |
Israeli H, Cohen-Dvashi H, Shulman A, et al. (2017) Mapping of the Lassa virus LAMP1 binding site reveals unique determinants not shared by other old world arenaviruses. Plos Pathogens. 13: e1006337 |
Cohen-Dvashi H, Israeli H, Shani O, et al. (2016) The role of LAMP1 binding and pH sensing by the spike complex of Lassa virus. Journal of Virology |
Cohen-Dvashi H, Cohen N, Israeli H, et al. (2015) Molecular Mechanism for LAMP1 Recognition by Lassa Virus. Journal of Virology. 89: 7584-92 |
Kedmi M, Ben-Chetrit N, Körner C, et al. (2015) EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer. Science Signaling. 8: ra29 |
Cohen-Dvashi H, Ben-Chetrit N, Russell R, et al. (2015) Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression. Embo Molecular Medicine. 7: 299-314 |
Ben-Chetrit N, Chetrit D, Russell R, et al. (2015) Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer. Science Signaling. 8: ra7 |